Higher tumour grade is also associated with an increase in the geminin/Ki67 ratio, signifying a shortening of G1 phase for the more malignant phenotype (grade 1: 0.29 vs grade 3: 0.36; P=0.07) and an increase in HER-2 expression (P=0.05). The gene discussed is ERBB2; the disease is neoplasm.